CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Abcam PLC (ADR) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Abcam PLC (ADR)
Discovery Drive
Cambridge Biomedical Campus, Hills Road
Phone: +44 1223696000p:+44 1223696000 CAMBRIDGE, CB20AX  United Kingdom Ticker: ABCMABCM
Business Summary
Abcam plc is a global life science company. The Company serves customers at the forefront of life science research through the identification, development, and distribution of biological reagents. Its products are used by researchers around the world to study biological pathways critical for scientific research, diagnostics, and drug discovery. It offers a selection of products in its catalogue to support research on proteins in biological pathways. Its principal catalogue product lines include primary and secondary antibodies, conjugated antibodies and conjugation kits, and singleplex immunoassays. It offers a range of peptides and proteins, which include cytokines, growth factors, and enzymes. It offers a range of knockout cell lines and lysates, which are used for its in-house validation needs and are also made available to its customers for their own research. It offers a variety of other products, including cellular activity kits, biochemicals and cell signaling pathway tools.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board Peter V.Allen 67 1/1/2022 6/18/2018
Chief Executive Officer, Executive Director Alan T.Hirzel 55 9/8/2014 1/1/2013
Chief Financial Officer, Executive Director Michael S.Baldock 59 2/3/2020 2/3/2020
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Abcam (US) Ltd.
Abcam Trading (Shanghai) Co. Ltd.
Abcam US Group Holdings Inc.
4 additional Business Names available in full report.

General Information
Number of Employees: 1,800 (As of 12/31/2022)
Outstanding Shares: 229,723,147 (As of 8/24/2023)
Stock Exchange: NASD
Federal Tax Id: 980487031
Fax Number: +44 1223215215


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, September 29, 2023